CancerTools Blogs

Introduction to the CancerTools.org Organoid Portfolio

Written by Product Management Team | May 19, 2023 9:32:42 AM

Patient-derived tumour Organoids

Organoids are unique self-organising 3D microscopic structures derived from cells that represent a physiologically relevant in vitro model systems as they preserve the genomic, physiological characteristics and multicellularity of the equivalent in vivo tissue.

 

 

Key Features

  • Preserve parental tissue genetic profile and morphology: various characterisation tests confirm F-PDOs retain parental tissue genetic profile and morphology

  • Amenable to extended culture duration: genetically and phenotypically stable for 6 -12 months in culture and after cryopreservation

  • Suspension culture: no extracellular matrix required

  • In  vivo tumorigenesis: suitable for PDX mouse development - gene expression profiles of the xenografts are similar to those of their source F-PDOs and tissues 

  • Suitable for various assays: F-PDOs can be used to establish high-throughput assays to evaluate anticancer agents and antibodies

  • Well-characterized with annotation data: the organoids have been characterised using comprehensive gene expression, whole-exome sequencing and morphological analyses

 

Applications

  • Disease modelling 
  • Anticancer agents discovery and development
  • Immuno-oncology assays
  • Compounds’ safety and toxicity testing
  • 3D imaging